Targeting Copper Homeostasis Improves Functioning of vps13Δ Yeast Mutant Cells, a Model of VPS13-Related Diseases
Open Access
- 24 February 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5), 2248
- https://doi.org/10.3390/ijms22052248
Abstract
Ion homeostasis is crucial for organism functioning, and its alterations may cause diseases. For example, copper insufficiency and overload are associated with Menkes and Wilson’s diseases, respectively, and iron imbalance is observed in Parkinson’s and Alzheimer’s diseases. To better understand human diseases, Saccharomyces cerevisiae yeast are used as a model organism. In our studies, we used the vps13Δ yeast strain as a model of rare neurological diseases caused by mutations in VPS13A–D genes. In this work, we show that overexpression of genes encoding copper transporters, CTR1, CTR3, and CCC2, or the addition of copper salt to the medium, improved functioning of the vps13Δ mutant. We show that their mechanism of action, at least partially, depends on increasing iron content in the cells by the copper-dependent iron uptake system. Finally, we present that treatment with copper ionophores, disulfiram, elesclomol, and sodium pyrithione, also resulted in alleviation of the defects observed in vps13Δ cells. Our study points at copper and iron homeostasis as a potential therapeutic target for further investigation in higher eukaryotic models of VPS13-related diseases.Funding Information
- Narodowe Centrum Nauki (2018/31/N/NZ3/03076, 2015/19/B/NZ3/01515)
This publication has 123 references indexed in Scilit:
- The Yeast Environmental Stress Response Regulates Mutagenesis Induced by Proteotoxic StressPLoS Genetics, 2013
- Biogenesis and assembly of eukaryotic cytochrome c oxidase catalytic coreBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2012
- Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug ElesclomolPLOS ONE, 2012
- VPS13Regulates Membrane Morphogenesis During Sporulation inSaccharomyces cerevisiaeJournal of Cell Science, 2012
- Zinc Pyrithione Inhibits Yeast Growth through Copper Influx and Inactivation of Iron-Sulfur ProteinsAntimicrobial Agents and Chemotherapy, 2011
- Increased iron supplied through Fet3p results in replicative life span extension of Saccharomyces cerevisiae under conditions requiring respiratory metabolismExperimental Gerontology, 2011
- A yeast-based assay identifies drugs active against human mitochondrial disordersProceedings of the National Academy of Sciences of the United States of America, 2011
- A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptidesBMC Microbiology, 2010
- Metabolic Response to Iron Deficiency in Saccharomyces cerevisiaePublished by Elsevier BV ,2010
- Live imaging of yeast Golgi cisternal maturationNature, 2006